Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry
Top Cited Papers
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Lunds Universitet
- Region Skåne
- Swedish Heart and Lung Association
- NIHR Imperial Biomedical Research Centre
- Region Uppsala
- Uppsala Universitet
This publication has 37 references indexed in Scilit:
- Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with EvolocumabNEJM Evidence, 2025
- Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction (“Jena auf Ziel”)Clinical Research in Cardiology, 2023
- Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial InfarctionJAMA, 2022
- Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial InfarctionJACC: Cardiovascular Imaging, 2022
- Influence of Ezetimibe on Plaque Morphology in Patients with ST Elevation Myocardial Infarction Assessed by Optical Coherence Tomography: An OCTIVUS Sub-StudyCardiovascular Revascularization Medicine, 2020
- Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial InfarctionJAMA Cardiology, 2020
- Adherence to Blood Cholesterol Treatment Guidelines Among Physicians Managing Patients With Atherosclerotic Cardiovascular DiseaseThe American Journal of Cardiology, 2019
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood CholesterolJACC, 2019
- Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein CholesterolJAMA Cardiology, 2017
- Early and Late Benefits of High-Dose Atorvastatin in Patients With Acute Coronary SyndromesJACC, 2005